Skip to main content
SpringerLink
Log in
Birkhäuser

New Cytokines as Potential Drugs

  • Conference proceedings
  • © 2000

Overview

Editors:
  1. Satwant K. Narula

    1. Schering-Plough Research Institute, Kenilworth, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Robert Coffman

    1. DNAX Research Institute, Palo Alto, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Progress in Inflammation Research (PIR)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (8 papers)

  1. Front Matter

    Pages i-xi
    Download chapter PDF

  2. Interleukin 5

    • Francis M. Cuss
    Pages 1-13

  3. Interleukin 10

    • Satwant Narula, Sidney Smith, Paul Grint
    Pages 15-29

  4. Interleukin 16

    • William W. Cruikshank, Hardy Kornfeld, David M. Center
    Pages 31-51

  5. Interleukin 17

    • François Fossiez, Jean-François Nicolas, Serge Lebecque
    Pages 53-58

  6. Interleukin 18

    • Masashi Kurimoto
    Pages 59-80

  7. FLT3 ligand

    • Hilary J. McKenna
    Pages 81-100

  8. Keratinocyte growth factor-2

    • Pablo A. Jimenez, Dale Greenwalt, Donna L. Mendrick, Mark A. Rampy, Jeffrey Su, Kam H. Leung et al.
    Pages 101-119

  9. Chemokines

    • Sergio A. Lira, Paul J. Zavodny, Daniel Lundell
    Pages 121-138

  10. Back Matter

    Pages 139-141
    Download chapter PDF
Back to top

Keywords

About this book

Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide...

Editors and Affiliations

  • Schering-Plough Research Institute, Kenilworth, USA

    Satwant K. Narula

  • DNAX Research Institute, Palo Alto, USA

    Robert Coffman

Bibliographic Information

  • Book Title: New Cytokines as Potential Drugs

  • Editors: Satwant K. Narula, Robert Coffman

  • Series Title: Progress in Inflammation Research

  • DOI: https://doi.org/10.1007/978-3-0348-8456-3

  • Publisher: Birkhäuser Basel

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Basel AG 2000

  • Hardcover ISBN: 978-3-7643-5883-9Published: 14 February 2000

  • Softcover ISBN: 978-3-0348-9575-0Published: 23 October 2012

  • eBook ISBN: 978-3-0348-8456-3Published: 19 November 2012

  • Series ISSN: 1422-7746

  • Series E-ISSN: 2296-4525

  • Edition Number: 1

  • Number of Pages: XI, 141

  • Topics: Internal Medicine, Biomedicine general, Immunology

Publish with us

Policies and ethics

Back to top

Search

Navigation